Biocom California appoints Tim Scott as President and CEO
Biocom California, the association representing the California life science industry, yesterday announced that it has named Tim Scott as its president and CEO, effective January 1, 2025. Mr. Scott will succeed Joe Panetta, Biocom California’s current president and CEO, who has led the organization for 25 years. Mr. Scott has been active on the board […]
Kindeva Drug Delivery appoints Denis Johnson as COO
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, yesterday announced that Denis Johnson has joined the company as its new Chief Operating Officer (COO). Denis joins Kindeva to lead global operations for all Kindeva’s state-of-the-art manufacturing, research, and development facilities located across the U.S. and U.K. As COO, he will be dedicated to global operations, but […]
ProMed Pharma announces acquisition of SpineThera
SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 (1a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain) and ProMed Pharma LLC, a leading contract manufacturer of polymer-based drug releasing dosage forms and combination device components, announced yesterday that ProMed Pharma has acquired […]
Aptar inks enterprise agreement with Biogen
Aptar Digital Health, part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, has entered into an enterprise agreement with Biogen Inc. to operate and develop digital health solutions for neurological and rare diseases. As part of the agreement, Biogen will transfer ownership of select digital health solutions […]
ClinChoice Expands its Footprint to Southeast Asia by acquiring CSI
ClinChoice, a leading global Contract Research Organization (CRO), announced expanding its global footprint with the acquisition of CSI Medical Research (CSI). CSI is a regional clinical CRO with professional staff and partners located across Asia (SEA), Australia and New Zealand (ANZ), to provide innovative and cost-effective clinical solutions. Through this strategic acquisition, ClinChoice further broadens its global footprint and full-service […]
Aptar appoints Sarah Glickman to its Board of Directors
AptarGroup, Inc. , a global leader in drug and consumer product dosing, dispensing and protection technologies, yesterday announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. “We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah’s extensive […]
Massive Bio and CureMatch Partner to provide AI powered cancer treatment
Massive Bio, an AI-powered platform connecting patients with clinical trials and CureMatch, a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision medicine support for oncology, and have announced a transformative partnership aimed at revolutionizing cancer treatment through advanced genomics, artificial intelligence, and expansive clinical trial accessibility. Massive Bio and CureMatch will leverage […]
Heligenics announces precision genetics test for breast cancer therapeutics
Heligenics, a cutting-edge biotech company, announces a first-of-its-kind precision genetic test to select among drugs to treat breast cancer. There are multiple drugs available to treat breast cancer. Most patients become drug resistant, meaning that the cancer cells aren’t responding to the drug that is usually able to kill or weaken them. Although many patients […]
Iktos-Teijin Pharma Combine co-develop latest tech for new drug design
Iktos, a company specializing in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that provides comprehensive healthcare services to improve the quality of life, today announced a strategic collaboration agreement in Artificial Intelligence for new drug design. According to the industrial sources from […]
